Viewing Study NCT01923233


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-01-09 @ 2:19 PM
Study NCT ID: NCT01923233
Status: WITHDRAWN
Last Update Posted: 2020-01-22
First Post: 2013-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer
Sponsor: Mirror Biologics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module